Judah Frommer Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
74%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
58.8%
Neutral
29.4%
Negative
11.8%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Consumer Staples
Healthcare
Consumer Discretionary
Specialty Retail
Consumer Staples
Discount Stores
Food Distribution
Grocery Stores
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $191 |
16%
upside
| 1 | +2.9% |
0
%
| 6 Jan ‘26 2 days ago |
|
|
|
Equal-Weight
Downgraded
| $19 |
16%
upside
| 2 | -54% |
0
%
| 6 Jan ‘26 2 days ago |
|
|
|
Overweight
Initiated
| $36 |
97%
upside
| 1 | -12% |
0
%
| 1 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $19 |
69%
upside
| 2 | +26% |
0
%
| 14 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $101 |
13%
downside
| 3 | +397% |
0
%
| 12 Sep ‘25 3 months ago |
|
|
|
Equal-Weight
Maintained
| $26 |
1%
downside
| 1 | – |
–
| 2 Jul ‘25 6 months ago |
|
|
|
Equal-Weight
Maintained
| $129 |
0%
downside
| 2 | – |
–
| 5 Jun ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $43 |
57%
upside
| 2 | +19% |
0
%
| 9 May ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $24 |
60%
upside
| 1 | +129% |
0
%
| 14 Mar ‘25 10 months ago |
|
|
|
Underweight
Downgraded
| $22 |
33%
downside
| 1 | -29% |
0
%
| 14 Feb ‘25 10 months ago |
|
|
|
Underweight
Maintained
| $6 |
18%
downside
| 1 | -32% |
0
%
| 13 Jan ‘25 1 year ago |
|